Shawn Singh, JD, is the President, Chief Executive Officer, and Director of VistaGen Therapeutics. Based in San Francisco, California.
Shawn Singh, JD, is the President, Chief Executive Officer, and Director of VistaGen Therapeutics, a clinical-stage biopharmaceutical company publicly traded on NASDAQ under the ticker VTGN. He has led the company since its NASDAQ listing in May 2016, overseeing the development of assets including AV-101 toward Phase 3 clinical trials for anxiety, depression, and CNS disorders.
Full founder directory · Investor directory · Company funding database · Fundraising library